ELEKTA ANNOUNCES INSTALLATION OF LEKSELL GAMMA KNIFE® PERFEXION™ AT HAUKELAND UNIVERSITY HOSPITAL IN NORWAY

ELEKTA ANNOUNCES INSTALLATION OF LEKSELL GAMMA KNIFE® PERFEXION™ AT HAUKELAND
UNIVERSITY HOSPITAL IN NORWAY

Press Release 
Stockholm, Sweden, October 20, 2008

Haukeland University Hospital in Bergen, Norway installs the latest technology
for treatment of brain disorders.


Leksell Gamma Knife® Perfexion™ is the latest and most advanced solution on the
market for non-invasive treatment of brain disorders. This new generation
Leksell Gamma Knife is fully automated and has the ability to treat patients
with multiple brain metastases in much shorter times compared to other
technologies. 

Gamma Knife® surgery is used to manage numerous neurosurgical conditions,
including brain tumors such as metastatic cancer, as well as vascular
malformations and certain functional disorders. This unmatched method provides
pinpoint accuracy, is highly efficient and produces outstanding results.
Patients benefit from fast, painless treatment, often conducted in an outpatient
surgical setting without the need for general anesthesia or even convalescence.
To date, over 500,000 patients world wide have undergone Gamma Knife surgery. "Leksell Gamma Knife Perfexion technology represents a major advance in brain
radiosurgery," says Olof Sandén, Executive Vice President, Elekta Europe, Africa& Latin America. “It also offers enormous opportunities to treat lesions all
over the brain in a single treatment, while also ensuring excellent patient
comfort” he says. “We are pleased to see the considerable interest in the new
system, among both old and new users. Leksell Gamma Knife Perfexion was
introduced two years ago and today we have already installed around 30 systems
around the world”, Olof Sandén says. 

For further information, please contact:

Lena Schattauer, Investor Relations, Elekta AB
Tel: +46 8 587 257 22, +46 70 595 51 00, e-mail: lena.schattauer@elekta.com   


About Elekta

Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated state of the art tools and treatment planning systems for
radiation therapy and radiosurgery, as well as workflow enhancing software
systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and
resource-efficient solutions that offer confidence to both healthcare providers
and patients, Elekta aims to improve, prolong and even save patient lives,
making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000
hospitals globally, and every day more than 100,000 patients receive diagnosis,
treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is
located in Stockholm, Sweden, and the company is listed on the Nordic Exchange
under the ticker EKTAb. For more information about Elekta, please visit
www.elekta.com.